Methods for screening compounds that modulate lipid metabolism

Details Methods for screening compounds that modulate lipid metabolism Methods for screening compounds that modulate lipid metabolism

2007-08-14

2007-08-14

Saidha, Tekchand (Department: 1652)

Chemistry: molecular biology and microbiology

Enzyme , proenzyme; compositions thereof; process for...

Oxidoreductase

C435S252300, C435S320100, C435S136000, C435S069200, C536S023200

Reexamination Certificate

active

10415232

ABSTRACT:
Drug screening assays useful in the discovery of pharmaceutically active compounds for use in the treatment of diseases involving abnormal lipid metabolism including diabetic neuropathy are taught. In particular, the control region of delta-5-desaturase gene is taught as a target for the drug screening methods, which serve to identify nucleotides, proteins, compounds and/or other pharmacological agents, which modulate the activity of desaturase enzymes or regulate the level of expression of the desaturase genes. Cell-based and cell lysate assays are taught for detecting components that interact with the desaturase enzymes and modify fatty acid profiles. In addition, cell-based and cell lysate assays are used to identify functional and regulatory elements controlling expression of the desaturase genes as well as to screen for components that modulate the transcriptional activity of the desaturase genes. Also taught is the gene for rat delta-5-desaturase.

REFERENCES:
patent: 6432684 (2002-08-01), Mukerji et al.
patent: WO93/05182 (1993-03-01), None
patent: WO 00/20603 (2000-04-01), None
patent: WO 00/40705 (2000-07-01), None
patent: WO 00/53770 (2000-09-01), None
patent: WO 01/70993 (2001-09-01), None
Sequence search alignment between USP 6,432,684—Accession No. ABS71838 and Applicants' SEQ ID No. 1.
Sequence search alignment between US Patent 6,432,684—SEQ ID No. 12 and Applicants' SEQ ID No. 3].
T. Aki, et al., “Molecular Cloning and Functional Characterization of Rat Δ-6 Fatty Acid Desaturase,” Biochemical and Biophysical Research Communications, vol. 255, pp. 575-579 (1999).
K. Anderson, et al., “Five-Lipoxygenase Inhibitors Reduce PANC-1 Survival: The Mode of Cell Death and Synergism of MK886 with Gamma Linolenic Acid,” Anticancer Research 18:791-800 (1998).
M. Arisaka, et al., “Prostaglandin Metabolism in Children With Diabetes Mellitus. I. Plasma Prostaglandin E2, F2∞TXB2, and Serum Fatty Acid Levels,” Journal of Pediatric Gastroenterology and Nutrition, vol. 5:878-882 (1986).
J. Booyens, et al., “Chronic Arachidonic Acid Eicosanoid Imbalance: A Common Feature in Coronary Artery Disease, Hypercholesterolemia, Cancer and Other Important Diseases,” Medical Hypotheses 18:53-60 (1985).
R. Brenner, et al., “Effect of Arachidonic Acid in the Alloxan-Diabetic Rat,” American Journal of Physiology vol. 215, No. 1, pp. 63-70 (Jul. 1968).
P. Calder, “Immunoregulatory and Anti-inflammatory Effects of n-3 Polyunsaturated Fatty Acids,” Brazilian Journal of Medical and Biological Research 31:467-490 (1998).
G. Calviello, et al., “Dietary Supplementation with Eicosapentaenoic and Docosahexaenoic Acid Inhibits Growth of Morris Hepatocarcinoma 3924A in Rats: Effects on Proliferation and Apoptosis,” Int. J. Cancer, vol. 75, pp. 699-705 (1998).
S. Chavali, et al., “Decreased Production of Interleukin-6 and Prostaglandin E2Associated with Inhibition of Δ-5 Desaturation of ω6 Fatty Acids in Mice Fed Safflower Oil Diets Supplemented with Sesamol,” Prostaglandins, Leukotrienes and Essential Fatty Acids, vol. 61, No. 6, pp. 347-352 (1999).
H. Cho, et al., “Cloning, Expression, and Nutritional Regulation of the Mammalian Δ-6 Desaturase,” The Journal of Biological Chemistry, vol. 274, No. 1, pp. 471-477 (1999).
H. Cho, et al., “Cloning, Expression, and Fatty Acid Regulation of the Human Δ-5 Desaturase,” The Journal of Biological Chemistry, vol. 274, No. 52, pp. 37335-37339 (1999).
T. Coste, et al., “Beneficial Effects of Gamma Linolenic Acid Supplementation on Nerve Conduction Velocity, Na+, K+ ATPase Activity, and Membrane Fatty Acid Composition in Sciatic Nerve of Diabetic Rats,” J. Nutr. Biochem, 10:411-420 (1999).
C. Curtis, et al., “n-3 Fatty Acids Specifically Modulate Catabolic Factors Involved in Articular Cartilage Degradation,” The Journal of Biological Chemistry, vol. 275, No. 2, pp. 721-724 (2000).
A. Dang, et al., “Effect of Dietary Fats on Fatty Acid Composition and Δ5 Desaturase in Normal and Diabetic Rats,” Lipids, vol. 24, No. 10, pp. 882-889 (1989).
U. Das, “Essential Fatty Acid Metabolism in Patients With Essential Hypertension Diabetes Mellitus and Coronary Heart Disease,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 52, pp. 387-391 (1995).
P. Dobner, et al., “Low-density Lipoproteins Supply Phospholipid-Bound Arachidonic Acid for Platelet Eicosanoid Production,” American Physiological Society, vol. 275, pp. E777-E784 (1998).
P. du Toit, et al., “The Effect of Gamma-Linolenic Acid and Eicosapentaenoic Acid on Urokinase Activity,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 51, pp. 121-124 (1994).
F. Faas, et al., “Altered Fatty Acid Desaturation and Microsomal Fatty Acid Composition in the Streptozotocin Diabetic Rat,” Lipids, 15:953-961 (1980).
J. Falconer, et al., “Effect of Eicosapentaenoic Acid and Other Fatty Acids on the Growth in Vitro of Human Pancreatic Cancer Cell Lines,” J. Cancer, 69:826-832 (1994).
Y. Fujiwara, et al., “Immunochemical Evidence for the Enzymatic Difference of Δ6-Desaturase from Δ9- and Δ5-Desaturase in Rat Liver Microsomes,” Biochemical and Biophysical Research Communications, vol. 110, No. 1, pp. 36-41 (1983).
J. Gadek, et al., “Effect of Enteral Feeding with Eicosapentaenoic Acid, Gamma-linolenic Acid, and Antioxidants in Patients with Acute Respiratory Distress Syndrome,” Critical Care Medicine, vol. 27, No. 8, pp. 1409-1420 (1999).
A. Hansen, “Serum Lipid Changes and Therapeutic Effects of Various Oil in Infantile Eczema” Proc. Soc. Exp. Biol. Med., vol. 31, pp. 1160-1161 (1933).
L. Harbige, “Dietary n-6 and n-3 Fatty Acids in Immunity and Autoimmune Disease,” Proceedings of the Nutrition Society, vol. 57, pp. 555-562 (1998).
M. James,et al., “Dietary Polyunsaturated Fatty Acids and Inflammatory Mediator Production,” American Journal Clin., vol. 71 (supple):343S-348S (2000).
W. Jiang, et al., “Regulation of the Expressing of E-Caherin on Human Cancer Cells by γ-Lionolenic Acid (GLA),” Cancer Research, vol. 55, pp. 5043-5048 (1995).
W. Jiang, et al., “Inhibition of Hepatocyte Growth Factor-Induced Motility and In Vitro Invasion of Human Colon Cancer Cells by Gamma-Linolenic Acid,” British Journal of Cancer, vol. 71, pp. 744-752 (1995).
W. Jiang, et al., “Gamma Linolenic Acid Regulates Gap Junction Communication In Endothelial Cells and Their Interaction With Tumor Cells,” Prostaglandins, Leukotorienes and Essential Fatty Acids, vol. 56, No. 4, pp. 307-316 (1997).
W. Jiang., et al., “The effect of n-6 Polyunsaturated Fatty Acids on the Expression of nm-23 in Human Cancel Cells,” British Journal of Cancer, vol. 77, No. 5, pp. 731-738 (1998).
W. Jiang, et al., “Peroxisome Proliferator Activated Receptor-γ(PRAR-γ) Mediates the Action of Gamma Linolenic Acid in Breast Cancer Cells,” Prostaglandins, Leukotrienes and Essential Fatty Acids, vol. 62, No. 2, pp. 119-127 (2000).
P. Julu, “Influences of Evening Primrose Oil on Lipid Metabolism and Functions of Sensory Nerves in Diabetic Rats: Role of the Metabolic Pool of Essential Fatty Acids,” AOCS Press, III., U.S.A., pp. 168-175 (1998).
H. Kawashima, et al., “Nicardipine and Nifedipine Inhibit Fatty Acid Desaturases in Rat Liver Microsomes,” Biosci. Biotech. Biochem., vol. 60, No. 10, pp. 1672-1676 (1996).
H. Keen, et al., “Treatment of Diabetic Neuropathy with γ-Linolenic Acid,” Diabetes Care, vol. 16, pp. 8-15 (Jan. 1993).
W. Khan, et al., “Arachidonic Acid and Free Fatty Acids as Second Messengers and The Role of Protein Kinase C,” Cellular Signalling, vol. 7, No. 3, pp. 171-184 (1995).
P. Lai, et al., “Cell Cylce Arrest and In

Affiliated with

Also associated with

Rating

Methods for screening compounds that modulate lipid metabolism does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for screening compounds that modulate lipid metabolism, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for screening compounds that modulate lipid metabolism will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3894868